Henry Schein Enhances Homecare Solutions with Acentus Acquisition for Glucose Monitoring

Henry Schein Strengthens Homecare Solutions with Acentus Acquisition

Henry Schein, Inc., a leading global provider of healthcare solutions based in Melville, N.Y., recently announces its acquisition of Acentus, a national medical supplier known for its focus on Continuous Glucose Monitors (CGMs). This acquisition, revealed on November 20, 2024, marks a significant step for Henry Schein as it seeks to enhance its homecare solutions platform. Acentus, generating approximately $35 million in annual revenue, allows Henry Schein to bolster its offerings in the home medical supply market, aiming to meet the increasing demands of healthcare providers and patients alike. With this acquisition, Henry Schein reinforces its commitment to delivering essential medical supplies directly to patients' homes, thereby improving access to necessary healthcare products.

Stanley M. Bergman, Chairman and CEO of Henry Schein, emphasizes the strategic importance of the Acentus acquisition. He notes that it not only strengthens the company’s operational capabilities but also enhances its service model for clinics, health systems, and home care patients. This move aligns with the growing trend towards home-based healthcare solutions, as healthcare providers increasingly prioritize patient-centered care. With the addition of Acentus, Henry Schein's homecare medical products segment now boasts an impressive annual revenue exceeding $350 million, positioning the company as a formidable player in the homecare landscape.

The acquisition of Acentus follows Henry Schein's recent expansions, including the acquisitions of Prism Medical Products in 2021 and Shield Healthcare and Mini Pharmacy in 2023. These strategic moves reflect Henry Schein’s ongoing dedication to developing its homecare medical supply sector and enhancing its service delivery capabilities. The founders of Acentus—Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia—will join the Henry Schein team, bringing valuable expertise that is expected to contribute to further innovation and operational success within the company.

In addition to this acquisition, Henry Schein continues to serve over 1 million customers globally, offering a diverse range of more than 300,000 branded and private-brand items. The company reported sales of $12.3 billion in 2023 and operates in 33 countries, highlighting its significant global presence and commitment to improving clinical outcomes for healthcare professionals.

As Henry Schein integrates Acentus into its operations, the company is poised to further enhance its homecare solutions, ensuring that healthcare providers and patients receive timely access to critical medical supplies. This acquisition not only represents a growth opportunity for Henry Schein but also aligns with the overarching trend towards home-based healthcare, ensuring the company remains at the forefront of the evolving medical supply industry.